Pharmaceutical giant Pfizer is racing against time to save its deal to acquire obesity company Metsera Inc. after a rival bidder, Danish drugmaker Novo Nordisk, made a surprise offer that caused Metsera’s shares to jump over 25%. Pfizer was one of the original bidders and had agreed to buy Metsera for around $5 billion in September, but now it must act fast to either beat out Novo’s bid or walk away.
Source: https://www.bloomberg.com/news/articles/2025-10-30/pfizer-races-to-salvage-obesity-drugmaker-deal-after-novo-s-bid